nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CHRFAM7A—corpus luteum—hypothyroidism	0.142	0.165	CbGeAlD
Hexobarbital—CHRNA7—corpus luteum—hypothyroidism	0.115	0.133	CbGeAlD
Hexobarbital—GRIK2—cerebellar cortex—hypothyroidism	0.0866	0.101	CbGeAlD
Hexobarbital—CHRNA4—cochlea—hypothyroidism	0.0635	0.0737	CbGeAlD
Hexobarbital—GRIK2—nerve—hypothyroidism	0.0318	0.0369	CbGeAlD
Hexobarbital—CHRNA4—nerve—hypothyroidism	0.0255	0.0297	CbGeAlD
Hexobarbital—CYP2C19—urine—hypothyroidism	0.0241	0.028	CbGeAlD
Hexobarbital—CYP1A2—urine—hypothyroidism	0.0197	0.0229	CbGeAlD
Hexobarbital—CYP2C9—urine—hypothyroidism	0.0187	0.0217	CbGeAlD
Hexobarbital—CYP2E1—urine—hypothyroidism	0.0177	0.0206	CbGeAlD
Hexobarbital—CYP3A4—urine—hypothyroidism	0.0142	0.0165	CbGeAlD
Hexobarbital—GRIK2—heart—hypothyroidism	0.0118	0.0137	CbGeAlD
Hexobarbital—GABRA4—heart—hypothyroidism	0.0111	0.0129	CbGeAlD
Hexobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.011	0.079	CbGpPWpGaD
Hexobarbital—CHRNA7—heart—hypothyroidism	0.0096	0.0112	CbGeAlD
Hexobarbital—GABRA4—pituitary gland—hypothyroidism	0.00927	0.0108	CbGeAlD
Hexobarbital—CHRNA7—cardiovascular system—hypothyroidism	0.00906	0.0105	CbGeAlD
Hexobarbital—CHRNA4—cardiovascular system—hypothyroidism	0.00894	0.0104	CbGeAlD
Hexobarbital—CHRFAM7A—blood—hypothyroidism	0.00887	0.0103	CbGeAlD
Hexobarbital—CHRFAM7A—thyroid gland—hypothyroidism	0.00856	0.00995	CbGeAlD
Hexobarbital—CHRFAM7A—female gonad—hypothyroidism	0.00828	0.00962	CbGeAlD
Hexobarbital—GABRA3—thyroid gland—hypothyroidism	0.0082	0.00953	CbGeAlD
Hexobarbital—GRIA2—testis—hypothyroidism	0.00805	0.00936	CbGeAlD
Hexobarbital—GABRA5—testis—hypothyroidism	0.00755	0.00877	CbGeAlD
Hexobarbital—GRIA2—cerebellum—hypothyroidism	0.00744	0.00864	CbGeAlD
Hexobarbital—CHRFAM7A—testis—hypothyroidism	0.00734	0.00853	CbGeAlD
Hexobarbital—GABRA6—cerebellum—hypothyroidism	0.00719	0.00835	CbGeAlD
Hexobarbital—CHRNA7—adrenal gland—hypothyroidism	0.00717	0.00833	CbGeAlD
Hexobarbital—CHRNA7—blood—hypothyroidism	0.00717	0.00833	CbGeAlD
Hexobarbital—CHRNA4—adrenal gland—hypothyroidism	0.00707	0.00822	CbGeAlD
Hexobarbital—GABRA3—testis—hypothyroidism	0.00703	0.00817	CbGeAlD
Hexobarbital—CHRNA7—thyroid gland—hypothyroidism	0.00692	0.00804	CbGeAlD
Hexobarbital—GRIK2—cerebellum—hypothyroidism	0.00672	0.00781	CbGeAlD
Hexobarbital—CHRNA7—female gonad—hypothyroidism	0.00668	0.00777	CbGeAlD
Hexobarbital—GABRA2—adrenal gland—hypothyroidism	0.00633	0.00735	CbGeAlD
Hexobarbital—GABRA4—cerebellum—hypothyroidism	0.00633	0.00735	CbGeAlD
Hexobarbital—CHRNA7—testis—hypothyroidism	0.00593	0.00689	CbGeAlD
Hexobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00545	0.0391	CbGpPWpGaD
Hexobarbital—CHRNA4—cerebellum—hypothyroidism	0.0054	0.00628	CbGeAlD
Hexobarbital—GABRA2—cerebellum—hypothyroidism	0.00483	0.00562	CbGeAlD
Hexobarbital—CYP2C9—heart—hypothyroidism	0.00478	0.00556	CbGeAlD
Hexobarbital—GABRA1—cerebellum—hypothyroidism	0.00467	0.00543	CbGeAlD
Hexobarbital—CYP2C19—blood—hypothyroidism	0.00461	0.00535	CbGeAlD
Hexobarbital—CYP2C9—cardiovascular system—hypothyroidism	0.00452	0.00525	CbGeAlD
Hexobarbital—PTGS1—heart—hypothyroidism	0.00437	0.00508	CbGeAlD
Hexobarbital—CYP2E1—cardiovascular system—hypothyroidism	0.00428	0.00497	CbGeAlD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00424	0.0304	CbGpPWpGaD
Hexobarbital—PTGS1—cardiovascular system—hypothyroidism	0.00412	0.00479	CbGeAlD
Hexobarbital—CYP1A2—blood—hypothyroidism	0.00376	0.00437	CbGeAlD
Hexobarbital—PTGS1—pituitary gland—hypothyroidism	0.00365	0.00424	CbGeAlD
Hexobarbital—CYP1A2—thyroid gland—hypothyroidism	0.00363	0.00422	CbGeAlD
Hexobarbital—CYP2C19—liver—hypothyroidism	0.0036	0.00418	CbGeAlD
Hexobarbital—CYP2C9—blood—hypothyroidism	0.00357	0.00415	CbGeAlD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00345	0.0248	CbGpPWpGaD
Hexobarbital—CYP2E1—adrenal gland—hypothyroidism	0.00338	0.00393	CbGeAlD
Hexobarbital—CYP2E1—blood—hypothyroidism	0.00338	0.00393	CbGeAlD
Hexobarbital—CYP2E1—thyroid gland—hypothyroidism	0.00327	0.0038	CbGeAlD
Hexobarbital—PTGS1—adrenal gland—hypothyroidism	0.00326	0.00379	CbGeAlD
Hexobarbital—PTGS1—blood—hypothyroidism	0.00326	0.00379	CbGeAlD
Hexobarbital—PTGS1—thyroid gland—hypothyroidism	0.00315	0.00366	CbGeAlD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00311	0.0223	CbGpPWpGaD
Hexobarbital—PTGS1—female gonad—hypothyroidism	0.00304	0.00353	CbGeAlD
Hexobarbital—CYP1A2—liver—hypothyroidism	0.00294	0.00342	CbGeAlD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00283	0.0203	CbGpPWpGaD
Hexobarbital—CYP2E1—testis—hypothyroidism	0.0028	0.00325	CbGeAlD
Hexobarbital—CYP2C9—liver—hypothyroidism	0.00279	0.00324	CbGeAlD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00273	0.0196	CbGpPWpGaD
Hexobarbital—CYP3A4—blood—hypothyroidism	0.00272	0.00316	CbGeAlD
Hexobarbital—PTGS1—testis—hypothyroidism	0.0027	0.00313	CbGeAlD
Hexobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00267	0.0191	CbGpPWpGaD
Hexobarbital—CYP2E1—liver—hypothyroidism	0.00265	0.00307	CbGeAlD
Hexobarbital—CYP2E1—cerebellum—hypothyroidism	0.00259	0.003	CbGeAlD
Hexobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00243	0.0174	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—SLC5A7—hypothyroidism	0.00238	0.0171	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00238	0.0171	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00231	0.0166	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00222	0.016	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—SLC5A7—hypothyroidism	0.00217	0.0156	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00214	0.0153	CbGpPWpGaD
Hexobarbital—CYP3A4—liver—hypothyroidism	0.00213	0.00247	CbGeAlD
Hexobarbital—PTGS1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00205	0.0147	CbGpPWpGaD
Hexobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00204	0.0146	CbGpPWpGaD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.002	0.0144	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00198	0.0142	CbGpPWpGaD
Hexobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00198	0.0142	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00195	0.014	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00182	0.0131	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—SLC5A7—hypothyroidism	0.00182	0.0131	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—SLC5A7—hypothyroidism	0.00177	0.0127	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00174	0.0125	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0017	0.0122	CbGpPWpGaD
Hexobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0017	0.0122	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00168	0.012	CbGpPWpGaD
Hexobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00167	0.012	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—NEFL—hypothyroidism	0.00154	0.011	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00153	0.011	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.00152	0.0109	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.0015	0.0107	CbGpPWpGaD
Hexobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00149	0.0107	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00149	0.0107	CbGpPWpGaD
Hexobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00146	0.0105	CbGpPWpGaD
Hexobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00144	0.0103	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00143	0.0102	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—NEFL—hypothyroidism	0.0014	0.01	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00138	0.00988	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.00133	0.00954	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.00131	0.00937	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.00128	0.00921	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00127	0.00915	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00126	0.00903	CbGpPWpGaD
Hexobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00122	0.00878	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—NEFL—hypothyroidism	0.00117	0.00843	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—NEFL—hypothyroidism	0.00114	0.00817	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00112	0.00802	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0011	0.00788	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.00109	0.00785	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00109	0.00779	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00108	0.00774	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—VAV3—hypothyroidism	0.00101	0.00725	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—NEFL—hypothyroidism	0.000977	0.00701	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000965	0.00692	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00092	0.0066	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000886	0.00635	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000857	0.00615	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000842	0.00604	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000827	0.00593	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000815	0.00585	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000805	0.00577	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000715	0.00513	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000705	0.00506	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000702	0.00504	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00069	0.00495	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000675	0.00484	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000667	0.00478	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000593	0.00425	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000588	0.00422	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000582	0.00417	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000572	0.0041	CbGpPWpGaD
Hexobarbital—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000566	0.00406	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000548	0.00393	CbGpPWpGaD
Hexobarbital—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000521	0.00374	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000488	0.0035	CbGpPWpGaD
Hexobarbital—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000423	0.00303	CbGpPWpGaD
Hexobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000402	0.00289	CbGpPWpGaD
Hexobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000367	0.00263	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—IYD—hypothyroidism	0.000354	0.00254	CbGpPWpGaD
Hexobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000326	0.00234	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000326	0.00234	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000322	0.00231	CbGpPWpGaD
Hexobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000313	0.00225	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ATP5O—hypothyroidism	0.000301	0.00216	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—POMC—hypothyroidism	0.0003	0.00215	CbGpPWpGaD
Hexobarbital—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000297	0.00213	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000286	0.00205	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—TPO—hypothyroidism	0.000283	0.00203	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000281	0.00201	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000276	0.00198	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—IYD—hypothyroidism	0.000265	0.0019	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000263	0.00188	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000257	0.00184	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000254	0.00182	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000253	0.00182	CbGpPWpGaD
Hexobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000242	0.00173	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000235	0.00169	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ATP5O—hypothyroidism	0.000225	0.00162	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000225	0.00161	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—POMC—hypothyroidism	0.000224	0.00161	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000221	0.00159	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000217	0.00156	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—TPO—hypothyroidism	0.000212	0.00152	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—IYD—hypothyroidism	0.000204	0.00147	CbGpPWpGaD
Hexobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000196	0.00141	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—IYD—hypothyroidism	0.000186	0.00134	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000185	0.00133	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000174	0.00125	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000173	0.00124	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TPO—hypothyroidism	0.000163	0.00117	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—IYD—hypothyroidism	0.000159	0.00114	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000158	0.00114	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000158	0.00113	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000151	0.00109	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TPO—hypothyroidism	0.000149	0.00107	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000138	0.00099	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ATP5O—hypothyroidism	0.000135	0.000971	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—POMC—hypothyroidism	0.000135	0.000968	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—TSHB—hypothyroidism	0.000131	0.000941	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TPO—hypothyroidism	0.000127	0.000913	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—IYD—hypothyroidism	0.000123	0.000881	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000118	0.000846	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PIK3C2A—hypothyroidism	0.000117	0.000839	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000115	0.000827	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000104	0.000749	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000104	0.000747	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TPO—hypothyroidism	9.82e-05	0.000705	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—SLC5A5—hypothyroidism	9.82e-05	0.000704	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—TSHB—hypothyroidism	9.8e-05	0.000703	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	8.74e-05	0.000627	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TSHB—hypothyroidism	7.56e-05	0.000542	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—SLC5A5—hypothyroidism	7.34e-05	0.000526	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TSHB—hypothyroidism	6.9e-05	0.000495	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	6.74e-05	0.000484	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.65e-05	0.000477	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.15e-05	0.000441	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.06e-05	0.000435	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TSHB—hypothyroidism	5.89e-05	0.000423	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.66e-05	0.000406	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	5.25e-05	0.000377	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.18e-05	0.000372	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.16e-05	0.00037	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—POMC—hypothyroidism	5.14e-05	0.000369	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TSHB—hypothyroidism	4.55e-05	0.000326	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—SLC5A5—hypothyroidism	4.41e-05	0.000316	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	4.05e-05	0.000291	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—POMC—hypothyroidism	3.84e-05	0.000275	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.4e-05	0.000244	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—POMC—hypothyroidism	2.96e-05	0.000212	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—POMC—hypothyroidism	2.7e-05	0.000194	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—POMC—hypothyroidism	2.31e-05	0.000166	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—POMC—hypothyroidism	1.78e-05	0.000128	CbGpPWpGaD
